drugset
drugset / Trial / NCT00653380

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions

NCT00653380 ↗

Phase 1 Completed 24 enrolled Par Pharmaceutical, Inc. Anapharm · collab
RandomizedCrossoverOpen-label

Summary

To compare the rate and extent of absorption of doxycycline monohydrate capsules equivalent to 100 mg doxycycline (Par) versus Monodox (Oclassen Pharmaceuticals).

Timeline

Start
1999-09
Primary completion
1999-10
Completion
1999-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 100 mg —

Indications

No indication recorded.